Register today for the 2014 Stem Cell Meeting on the Mesa, October 7-9 in La Jolla, California! Join nearly 800 attendees for the sector's premier conference incorporating one-on-one meetings during the 4th Annual Partnering Forum as well as a full-day of in-depth scientific presentations during the 9th Annual Scientific Symposium.

Learn more about our three newly established technology sections - Cell Therapy, Gene and Gene-Modified Cell Therapy and Tissue Engineering and Biomaterials - aimed at ensuring that all major technology constituencies within ARM's membership are recognized as primary voices within the organization.

ARM's 2014 Annual Industry Report is now available for download! This year's report provides a comprehensive and detailed review of the financial and clinical activity of 400+ leading regenerative medicine and advanced therapy companies developing cellular-based therapies, gene therapies and gene-modified cell therapies.   

About ARM

Advancing Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations.
Learn more

Our Members

170+ and Growing
ARM’s membership is diverse, representing leading regenerative medicine companies and investors, university-based and non-profit research institutions, patient advocacy groups, pharmaceutical companies engaged in regenerative medicine research and other organizations supporting regenerative medicine.
Learn more